Unknown NA INTERVENTIONAL 1-arm NCT04728906

Heart Patch for Myocardial Infarction COVID-19

Targeted-cell Therapy Using Epithelial Stem Cells and Patients' Cardiomyocytes Loaded in Amnion Bilayer to Regenerate Myocardial Infarction Post COVID-19 Complication

Sponsor: Fakultas Kedokteran Universitas Indonesia

Conditions Heart Diseases Myocardial Infarction

Interventions Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells

Updated 5 times since 2021 Last updated: Feb 14, 2022 Started: Apr 1, 2022 Primary completion: Sep 1, 2022 Completion: Sep 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Heart Diseases and Myocardial Infarction and is currently ongoing. Fakultas Kedokteran Universitas Indonesia leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Apr 2022 — Mar 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2021 — Apr 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fakultas Kedokteran Universitas Indonesia
Pusat Jantung Nasional Harapan Kita
RSUPN dr. Cipto Mangunkusumo
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Rumah Sakit Universitas Indonesia

Data source: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Depok, Indonesia
• Jakarta, Indonesia